Dr. Monish Aron, MD
Urology (Urology Physician)
1516 San Pablo St Fl 5
Los Angeles, CA 90033
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 36
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 642
Licensed in California since 2011, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
CA license A117665 (first issued 2011; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Keck Hospital of Usc Los Angeles, CA
Medical groups
- Usc Care Medical Group Inc (1,380 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 642
- Services billed
- 1,404
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 657 | 412 |
| New patient office or other outpatient visit, 30-44 minutes | 106 | 106 |
| Established patient office or other outpatient visit, 30-39 minutes | 103 | 85 |
| Diagnostic exam of bladder and urethra using an endoscope | 101 | 69 |
| New patient office or other outpatient visit, 45-59 minutes | 81 | 81 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 49 | 49 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 47 | 47 |
| Telephone medical discussion with physician, 11-20 minutes | 46 | 41 |
| New patient office or other outpatient visit, 60-74 minutes | 27 | 27 |
| Established patient office or other outpatient visit, 40-54 minutes | 24 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Los Angeles, CA | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 6 payments worth $218 in total to this clinician.
| AbbVie Inc. | $103 |
|---|---|
| Axogen | $50.54 |
| Janssen Biotech, Inc. | $37.26 |
| Immunitybio, Inc. | $27.10 |
| Food and Beverage | $218 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $16,298 in research payments for these studies, mostly to the institutions running them.
- The HistoSonics Edison System for treatment of primary solid renal tumors using histotripsy
Histosonics, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.